Canadian Medical Center Co (SAU:4021) ROE %: 12.89% (As of Mar. 2026) — 20% Below Median


SAU:4021 Canadian Medical Center Co SAU:4021
83 GF Score
Price ﷼6.03
GF Value ﷼10.74
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Canadian Medical Center Co ROE %?

Canadian Medical Center Co SAU:4021 +0.50% 83 ROE % is 12.89% as of Mar. 2026, which is 20% below its 10-year median of 16.16. GuruFocus rates SAU:4021 with a GF Score™ of 83/100 and a GF Value™ of ﷼10.74 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 623 Healthcare Providers & Services companies, Canadian Medical Center Co ranks better than 51.2% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Canadian Medical Center Co's annualized net income for the quarter that ended in Mar. 2026 was ﷼12.2 Mil. Canadian Medical Center Co's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ﷼94.3 Mil. Therefore, Canadian Medical Center Co's annualized ROE % for the quarter that ended in Mar. 2026 was 12.89%.

The historical rank and industry rank for Canadian Medical Center Co's ROE % or its related term are showing as below:

SAU:4021' s ROE % Range Over the Past 10 Years
Min: 6.34   Med: 16.16   Max: 17.57
Current: 6.34

During the past 6 years, Canadian Medical Center Co's highest ROE % was 17.57%. The lowest was 6.34%. And the median was 16.16%.

SAU:4021's ROE % is ranked better than
51.2% of 623 companies
in the Healthcare Providers & Services industry
Industry Median: 5.86 vs SAU:4021: 6.34

Canadian Medical Center Co  (SAU:4021) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=12.156/94.295
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(12.156 / 152.176)*(152.176 / 136.7315)*(136.7315 / 94.295)
=Net Margin %*Asset Turnover*Equity Multiplier
=7.99 %*1.113*1.45
=ROA %*Equity Multiplier
=8.89 %*1.45
=12.89 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=12.156/94.295
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (12.156 / 14.112) * (14.112 / 16.32) * (16.32 / 152.176) * (152.176 / 136.7315) * (136.7315 / 94.295)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8614 * 0.8647 * 10.72 % * 1.113 * 1.45
=12.89 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Canadian Medical Center Co ROE % Related Terms


Canadian Medical Center Co ROE % Historical Data

* Premium members only.

The historical data trend for Canadian Medical Center Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canadian Medical Center Co ROE % Chart

Canadian Medical Center Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial 15.07 17.25 17.57 11.06 11.05

Canadian Medical Center Co Quarterly Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.22 3.42 14.30 -5.24 12.89

SAU:4021 vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Canadian Medical Center Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Canadian Medical Center Co ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Canadian Medical Center Co's ROE % distribution charts can be found below:

* The bar in red indicates where Canadian Medical Center Co's ROE % falls into.


SAU:4021
83GF Score
Canadian Medical Center Co SAU:4021
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Canadian Medical Center Co ROE % Calculation

Canadian Medical Center Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=10.497/( (93.87+96.051)/ 2 )
=10.497/94.9605
=11.05 %

Canadian Medical Center Co's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=12.156/( (96.051+92.539)/ 2 )
=12.156/94.295
=12.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 12.89% mean?
Canadian Medical Center Co (SAU:4021) has a ROE % of 12.89% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Canadian Medical Center Co and its competitors. This is 20% below median its historical median of 16.16. Over the past decade, Canadian Medical Center Co's ROE % has ranged from 6.34 to 17.57. According to the industry distribution chart, Canadian Medical Center Co ranks #304 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 48.8%.
Is Canadian Medical Center Co's ROE % too high?
Canadian Medical Center Co's current ROE % of 12.89% is 20% below median its 10-year median of 16.16. Over the past 10 years, this metric has ranged from a low of 6.34 to a high of 17.57. The Healthcare Providers & Services industry median ROE % is 5.86. Canadian Medical Center Co's value of 12.89% is 120% above this industry median. Based on the distribution chart, Canadian Medical Center Co ranks #304 out of 623 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Canadian Medical Center Co has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Canadian Medical Center Co's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Canadian Medical Center Co ranks #304 out of 623 companies for ROE %. This puts Canadian Medical Center Co in the upper half of its industry. The industry median ROE % is 5.86. Canadian Medical Center Co's value of 12.89% is 120% above this benchmark. Historically, Canadian Medical Center Co's own ROE % has ranged from 6.34 to 17.57 over the past decade. While the company's 10-year median is 16.16 vs. the industry median of 5.86, Canadian Medical Center Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.86, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Canadian Medical Center Co's current ROE % of 12.89% is 120% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Canadian Medical Center Co and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Canadian Medical Center Co's current ROE % is 12.89%, which is 20% below median its own 10-year median of 16.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canadian Medical Center Co stock overvalued right now?
Based on GuruFocus' analysis, Canadian Medical Center Co (SAU:4021) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼10.74, compared to a current price of ﷼6.03 — trading 43.9% below its estimated fair value. The current ROE % is 12.89%, which is 20% below median its 10-year median of 16.16 and 120% above the Healthcare Providers & Services industry median of 5.86. Canadian Medical Center Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Canadian Medical Center Co (SAU:4021), the current ROE % is 12.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Canadian Medical Center Co (SAU:4021) Overvalued in 2026?

Based on GuruFocus' analysis, Canadian Medical Center Co stock appears to be undervalued. The current stock price of ﷼6.03 is trading 43.9% below its estimated GF Value™ of ﷼10.74. GuruFocus considers Canadian Medical Center Co to be Significantly Undervalued.

Key valuation signals for SAU:4021:

  • ROE %: 12.89% (20% below median its 10-year median of 16.16)
  • GF Value™: ﷼10.74 vs. price of ﷼6.03 (43.9% below fair value)
  • GF Score™: 83/100 with 5 warning signs
  • Industry Position: 120% above the Healthcare Providers & Services median (#304 of 623)

No single metric tells the full story. See the SAU:4021 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Canadian Medical Center Co Business Description

Address Al-Ammar Avenue, Omar bin al Khattab Street, Building No. 1, Uhud, Dammam, SAU
Canadian Medical Center Co is a provider of emergency medical care solutions and integrated healthcare services management. The company offers a wide range of medical services, including operating on-site clinics, medical coverage for events and projects, and ambulance transportation services supported by a fleet of modern ambulances and trained and licensed medical teams. Its services include Medical Centers, Medical Support at Onshore and Offshore Sites, Medical Support at Construction Sites, Medical Support at Industrial Sites, Medical Coverage for Events, Ambulance Services, Home Health Care, Medical Training, Medical Examinations, and Ambulance Transports.
83GF Score

Get the complete analysis for SAU:4021

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼6.03
Price
﷼10.74
GF Value